Send us Fan Mail

Here is Part 2 of our two-part series on Clinical Trials from the Patient Perspective.  This time we hear from the experts who have solutions to the issues raised in Part 1.  We continue to explore how research processes were impacted by Covid 19 and the race to find vaccines and treatments.  Spoiler Alert – there are some Covid silver linings for those of us looking for change in MBC research.  Co-hosts Jim Kremens, Lisa Laudico, and Sarah Mann, speak with experts Susan Colen of BreastCancerTrials.org, Deb Collyar of PAIR, Dr. Neal Fischbach of Yale New Haven Health, bioethicist Jill Manning of Mass General Brigham, Dr. Corrie Painter of Count Me In and the Broad Institute, Kristin Schneeman of Faster Cures and the Milken Institute along with MBC Patient Advocates, Christine Hodgdon of GRASP & Stormriders.org and Lianne Kraemer. 

Want more information, please check out our extensive episode notes for this episode including an infographic that describes the clinical trial search landscape for individuals living with MBC. 

Look for a full episode on April 5 covering our interview with Judy Perkins.  

More info available on our website www.ourmbclife.org

Got something to Share? Feedback? 

Email:  [email protected]  

Send us a voice recording via email or through speakpipe on our website. 

Follow on Facebook, Instagram, and Twitter @ourmbclife 

We’re so happy you joined us! If this conversation resonated with you please share it with someone who might need it. Don't forget to like and subscribe here to follow us on your favorite podcast platform so you never miss an episode. You can find more episodes, resources and ways to get involved on our website Our MBC Life. Have a topic you’d like us to cover? Email us at [email protected]. And don’t forget to follow us on our socials @ourmbclife. 

Remember you are not alone.